We delivered strong performance and upgraded our growth outlooks. Broad-based performance drove sales, profits and earnings growth.

27 февр. 2024 г. · The parent company financial statements for the year ended 31 December 2023, comprising the balance sheet and the statement of changes in equity ...

Download our 2023 Annual Report and ESG Performance Report · Annual Report 2023(PDF - 8.0MB) · ESG Performance Report 2023(PDF - 2.0MB) · Cautionary statement 2023 ...

Most Recent Annual Report. Glaxosmithkline plc. MOST RECENT 2023 Annual Report. View PDF. Glaxosmithkline plc does not currently have ...

27 февр. 2024 г. · ... report | Governance and remuneration | Financial statements | Investor information. 2023 Annual Report on Form 20-F. Form 20-F Cross Reference ...

Annual Report 2023 (PDF - 8.0MB) · ESG Performance Report 2023 (PDF - 2.0MB) · Annual Report 2023 iXBRL viewer · Annual Report 2023 ESEF (ZIP - 6.5MB) ...

22 апр. 2024 г. · The development, performance and position of the Group are discussed in the Group's 2023 annual report which does not form part of this report.

25 мар. 2024 г. · GSK Annual Report 2023. Financial record continued. 274. Page 4. Three-year selected financial data. A record of financial performance is ...

22 апр. 2024 г. · The Directors present their report and the audited financial statements of GSK Capital B.V. (the "Company") for the year ended 31 December 2023.

This interactive publication is created with FlippingBook, a service for streaming PDFs online. No download, no waiting. Open and start reading right away!